Virax Biolabs Group Ltd. Class A (VRAX) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Virax Biolabs Group Ltd. has partnered with French company Tebubio to distribute its ImmuneSelect portfolio across the European Union, Norway, and Switzerland. This collaboration aims to enhance the accessibility of ImmuneSelect products, which are crucial for researching adaptive immunity. The products, optimized for stimulating T cells, are intended for research use and not for diagnostic purposes.
For further insights into VRAX stock, check out TipRanks’ Stock Analysis page.